A detailed history of Silverberg Bernstein Capital Management LLC transactions in Ac Immune Sa stock. As of the latest transaction made, Silverberg Bernstein Capital Management LLC holds 10,000 shares of ACIU stock, worth $30,000. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$30,000
Previous $39.9 Million 5.26%
% of portfolio
0.03%
Previous 0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$2.29 - $4.87 $22,900 - $48,700
10,000 New
10,000 $39.9 Million

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $250M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Silverberg Bernstein Capital Management LLC Portfolio

Follow Silverberg Bernstein Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverberg Bernstein Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverberg Bernstein Capital Management LLC with notifications on news.